WorkshopsOpportunitiesConferences & CFPsJournal FinderCV MakerResearch TrackerPeopleSign InRegister
Journal Finder

Drug Metabolism and Personalized Therapy

ISSN 2363-8907 · eISSN 2363-8915Active
Official Website
Publisher
Walter de Gruyter GmbH
Country
Germany
Subject Areas
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Pharmacology (medical)

Indexing & Recognition

Data sourced from official lists. Always cross-verify with the primary indexing database.

Scopus
Source: Scopus Source List
ListedQuartile Q2 · H-Index 41 · Coverage 2015–2026
Last verified: 4 Jun 2026
Web of Science
ABDC
Not listed
DOAJ
Not listed

Verification Sources

This record was compiled from the following sources. Data may not reflect real-time changes — always verify with the primary source.

Scopus Source ListVisit →

Data is provided for informational purposes only and may be outdated — always verify with the primary source before submitting. Academint is not affiliated with these providers. Sources & attribution →

Record last updated: 4 June 2026

Similar Journals

In the same subject area and a similar tier. Tap to explore.

Q2
Current Reviews in Clinical and Experimental Pharmacology
Bentham Science Publishers
Q2
Journal of Applied Pharmaceutical Science
Open Science Publishers LLP Inc.
Q2
Expert Opinion on Orphan Drugs
Taylor and Francis Ltd.
Q2
Bioanalysis
Taylor and Francis Ltd.
Q2
Iranian Journal of Pharmaceutical Research
Brieflands
Q2
Pharmacoepidemiology
MDPI AG
Q2
Mental Health Clinician
American Association of Psychiatric Pharmacists
Q2
Journal of Anaesthesiology Clinical Pharmacology
Wolters Kluwer Medknow Publications
Q1
Current Protocols
John Wiley and Sons Inc
Q3
Research Results in Biomedicine
Belgorod State National Research University
Q3
Journal of Research in Pharmacy
Marmara University
Q1
Therapeutic Innovation and Regulatory Science
Springer Science and Business Media Deutschland GmbH

Comments

Share your experience with Drug Metabolism and Personalized Therapy — review timelines, peer-review quality, fees, or anything useful to other researchers. Comments are public.

Loading comments…